{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:13:11Z","timestamp":1789413191288,"version":"build-2803163510"},"reference-count":102,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cheil-nammyung Foundation Research Fund"},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1D1A1A01060777"],"award-info":[{"award-number":["2015R1D1A1A01060777"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["K16281"],"award-info":[{"award-number":["K16281"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0169675","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T17:48:51Z","timestamp":1483984131000},"page":"e0169675","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2815-5886","authenticated-orcid":true,"given":"Yeoun-Hee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Chang","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Il","family":"Gum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Bin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Yeul","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoo Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8959-4033","authenticated-orcid":true,"given":"Young Jeung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1167\/iovs.09-4921","article-title":"Effect of TIMP-1 and MMP in pterygium invasion","volume":"51","author":"YY Tsai","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/02713689408999878","article-title":"Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells","volume":"13","author":"N Dushku","year":"1994","journal-title":"Curr Eye Res"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00417-003-0846-y","article-title":"Distribution of extracellular matrix proteins in pterygia: an immunohistochemical study","volume":"242","author":"W Naib-Majani","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/ICL.0b013e3181eea8fe","article-title":"What a study of pterygia teaches us about the cornea? Molecular mechanisms of formation","volume":"36","author":"TW Reid","year":"2010","journal-title":"Eye Contact Lens"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1167\/iovs.11-7941","article-title":"Involvement of SPARC and MMP-3 in the pathogenesis of human pterygium","volume":"53","author":"LF Seet","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1542-0124(12)70103-9","article-title":"The pathogenesis of pterygium: current concepts and their therapeutic implications","volume":"6","author":"J Chui","year":"2008","journal-title":"The ocular surface"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/bjo.77.11.734","article-title":"Pterygium as an early indicator of ultraviolet insolation: a hypothesis","volume":"77","author":"MT Coroneo","year":"1993","journal-title":"The British journal of ophthalmology"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00055735-199908000-00011","article-title":"The pathogenesis of pterygia","volume":"10","author":"MT Coroneo","year":"1999","journal-title":"Current opinion in ophthalmology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0002-9394(60)90245-2","article-title":"Pterygium: its incidence, heredity and etiology","volume":"50","author":"JH Hilgers","year":"1960","journal-title":"American journal of ophthalmology"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/bjo.68.5.347","article-title":"Pterygium in welders","volume":"68","author":"I Karai","year":"1984","journal-title":"The British journal of ophthalmology"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0002-9394(99)00161-0","article-title":"Sun exposure and pterygium of the eye: a dose-response curve","volume":"128","author":"TJ Threlfall","year":"1999","journal-title":"American journal of ophthalmology"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0960-894X(98)00128-0","article-title":"Structural insight into the binding motifs for the calcium ion and the non-catalytic zinc in matrix metalloproteases","volume":"8","author":"I Massova","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"issue":"31","key":"ref13","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"H Nagase","year":"1999","journal-title":"J Biol Chem"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00418-010-0751-5","article-title":"Proliferative and migratory aptitude in pterygium","volume":"134","author":"H Bai","year":"2010","journal-title":"Histochem Cell Biol"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/bjo.67.9.604","article-title":"Histology of pterygium: an electron microscopic study","volume":"67","author":"ME Cameron","year":"1983","journal-title":"The British journal of ophthalmology"},{"issue":"4","key":"ref16","first-page":"353","article-title":"Detection and comparison of matrix metalloproteinase in primary and recurrent pterygium fibroblasts","volume":"4","author":"MX An","year":"2011","journal-title":"Int J Ophthalmol"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bjo.2008.151852","article-title":"The science of pterygia","volume":"94","author":"JC Bradley","year":"2010","journal-title":"The British journal of ophthalmology"},{"issue":"3","key":"ref18","first-page":"161","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"M Egeblad","year":"2002","journal-title":"Nature reviews"},{"issue":"2","key":"ref19","first-page":"404","article-title":"Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts","volume":"41","author":"DQ Li","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"ref20","first-page":"1963","article-title":"Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis","volume":"42","author":"N Di Girolamo","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2\u20134","key":"ref21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1155\/2000\/82708","article-title":"In vitro and in vivo expression of interstitial collagenase\/MMP-1 by human mast cells","volume":"7","author":"N Di Girolamo","year":"2000","journal-title":"Dev Immunol"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archopht.119.5.695","article-title":"Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells","volume":"119","author":"N Dushku","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00418-004-0705-x","article-title":"Involvement of metalloprotease-2 in the development of human brain microvessels","volume":"122","author":"F Girolamo","year":"2004","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"ref24","first-page":"71","article-title":"Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts","volume":"119","author":"DQ Li","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"ref25","first-page":"2154","article-title":"Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines","volume":"41","author":"A Solomon","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"ref26","first-page":"4142","article-title":"Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head","volume":"41","author":"N Di Girolamo","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1167\/iovs.08-3147","article-title":"Increased expression of gelatinase (MMP-2 and MMP-9) in pterygia and pterygium fibroblasts with disease progression and activation of protein kinase C","volume":"50","author":"SF Yang","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ophtha.2005.01.023","article-title":"Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia","volume":"112","author":"M Gebhardt","year":"2005","journal-title":"Ophthalmology"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00003226-200307000-00015","article-title":"Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia","volume":"22","author":"J Jin","year":"2003","journal-title":"Cornea"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/00003226-200110000-00013","article-title":"Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia","volume":"20","author":"DH Lee","year":"2001","journal-title":"Cornea"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1076\/ceyr.25.1.17.9959","article-title":"Angiogenesis in pterygium: morphometric and immunohistochemical study","volume":"25","author":"AL Marcovich","year":"2002","journal-title":"Curr Eye Res"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.4049\/jimmunol.161.12.6845","article-title":"Matrix metalloproteinases generate angiostatin: effects on neovascularization","volume":"161","author":"LA Cornelius","year":"1998","journal-title":"J Immunol"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1172\/JCI6870","article-title":"Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention","volume":"103","author":"WG Stetler-Stevenson","year":"1999","journal-title":"J Clin Invest"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/jor.22147","article-title":"Impaired biomechanical properties correlate with neoangiogenesis as well as VEGF and MMP-3 expression during rat patellar tendon healing","volume":"30","author":"H Sahin","year":"2012","journal-title":"J Orthop Res"},{"issue":"3\u20134","key":"ref35","first-page":"151","article-title":"Activation mechanisms of matrix metalloproteinases","volume":"378","author":"H Nagase","year":"1997","journal-title":"Biol Chem"},{"issue":"1","key":"ref36","first-page":"324","article-title":"Plasmin and matrix metalloproteinases in vascular remodeling","volume":"86","author":"HR Lijnen","year":"2001","journal-title":"Thromb Haemost"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"e42596","DOI":"10.1371\/journal.pone.0042596","article-title":"MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability","volume":"7","author":"M Toriseva","year":"2012","journal-title":"PLoS One"},{"issue":"46","key":"ref38","doi-asserted-by":"crossref","first-page":"38716","DOI":"10.1074\/jbc.M112.373159","article-title":"Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis","volume":"287","author":"Y Kudo","year":"2012","journal-title":"J Biol Chem"},{"issue":"26","key":"ref39","doi-asserted-by":"crossref","first-page":"27633","DOI":"10.1074\/jbc.M313617200","article-title":"Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3)","volume":"279","author":"A Zijlstra","year":"2004","journal-title":"J Biol Chem"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/jid.2009.130","article-title":"Stromal expression of MMP-13 is required for melanoma invasion and metastasis","volume":"129","author":"P Zigrino","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2353\/ajpath.2009.081080","article-title":"MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing","volume":"175","author":"N Hattori","year":"2009","journal-title":"Am J Pathol"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s007740200020","article-title":"Inhibition of growth plate angiogenesis and endochondral ossification with diminished expression of MMP-13 in hypertrophic chondrocytes in FGF-2-treated rats","volume":"20","author":"H Nagai","year":"2002","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00018-010-0476-6","article-title":"Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization","volume":"68","author":"J Lecomte","year":"2011","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/carcin\/bgp248","article-title":"MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma","volume":"31","author":"W Lederle","year":"2010","journal-title":"Carcinogenesis"},{"issue":"Suppl 2","key":"ref45","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.3816\/CCC.2004.s.010","article-title":"Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer","volume":"4","author":"H Hurwitz","year":"2004","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1111\/aos.12119","article-title":"Bevacizumab in age-related macular degeneration: a randomized controlled trial on the effect of injections every 4 weeks, 6 weeks and 8 weeks","volume":"91","author":"T Lushchyk","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/bjophthalmol-2012-302451","article-title":"Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema","volume":"97","author":"C Zehetner","year":"2013","journal-title":"The British journal of ophthalmology"},{"issue":"7","key":"ref48","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1755-3768.2008.01346.x","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patients","volume":"87","author":"KB Pedersen","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1755-3768.2008.01312.x","article-title":"Efficacy of intravitreal bevacizumab (Avastin) therapy for early and advanced neovascular age-related macular degeneration","volume":"87","author":"I Krebs","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"ref50","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bjo.2007.120303","article-title":"Anti-VEGF for neovascular ARMD: visual improvement as the goal of therapy?","volume":"91","author":"S Bopp","year":"2007","journal-title":"The British journal of ophthalmology"},{"issue":"3","key":"ref51","first-page":"273","article-title":"Intravitreal bevacizumab: an analysis of the evidence","volume":"1","author":"DP Smit","year":"2007","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10792-015-0076-4","article-title":"A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study","volume":"36","author":"Q Motarjemizadeh","year":"2016","journal-title":"Int Ophthalmol"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.clinthera.2015.08.023","article-title":"Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: a randomized controlled trial","volume":"37","author":"N Kasetsuwan","year":"2015","journal-title":"Clin Ther"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/jop.2014.0060","article-title":"Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up","volume":"31","author":"A Nava-Castaneda","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10792-013-9852-1","article-title":"Subconjunctival bevacizumab in the impending recurrent pterygia","volume":"34","author":"SA Bayar","year":"2014","journal-title":"Int Ophthalmol"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bjophthalmol-2013-303436","article-title":"Vascular endothelial growth factor gene polymorphism and protein expression in the pathogenesis of pterygium","volume":"98","author":"ML Peng","year":"2014","journal-title":"The British journal of ophthalmology"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/ICO.0000000000000037","article-title":"Bevacizumab in the treatment of pterygium: a meta-analysis","volume":"33","author":"Q Hu","year":"2014","journal-title":"Cornea"},{"issue":"3","key":"ref58","first-page":"179","article-title":"Subconjunctival bevacizumab injection in treatment of pterygium","volume":"49","author":"MR Besharati","year":"2011","journal-title":"Acta Med Iran"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ICO.0000000000000291","article-title":"Topical cyclosporine in corneal transplantation","volume":"34","author":"M Ziaei","year":"2015","journal-title":"Cornea"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00003226-199309000-00008","article-title":"Topical cyclosporin A in the treatment of anterior segment inflammatory disease","volume":"12","author":"EJ Holland","year":"1993","journal-title":"Cornea"},{"issue":"10","key":"ref61","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s004170050321","article-title":"Efficacy of subconjunctival cyclosporin-containing microspheres on keratoplasty rejection in the rabbit","volume":"237","author":"MV de Rojas Silva","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2\u20133","key":"ref62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"S Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"issue":"6","key":"ref63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000151740","article-title":"Topical cyclosporine A in the prevention of pterygium recurrence","volume":"222","author":"O Yalcin Tok","year":"2008","journal-title":"Ophthalmologica"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2147\/OPTH.S19469","article-title":"The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery","volume":"5","author":"E Turan-Vural","year":"2011","journal-title":"Clin Ophthalmol"},{"issue":"Suppl 7","key":"ref65","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.5301\/ejo.5000004","article-title":"Topical cyclosporine A administration after pterygium surgery","volume":"22","author":"K Ozulken","year":"2012","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"ref66","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3341\/kjo.2015.29.6.375","article-title":"A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery","volume":"29","author":"S Hwang","year":"2015","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"ref67","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10792-015-0106-2","article-title":"In vitro study of cyclosporine A 0.05% on primary and recurrent pterygium fibroblasts","volume":"36","author":"MM Viveiros","year":"2016","journal-title":"Int Ophthalmol"},{"issue":"9","key":"ref68","doi-asserted-by":"crossref","first-page":"e24793","DOI":"10.1371\/journal.pone.0024793","article-title":"Synergistic inhibition of endothelial cell proliferation, tube formation, and sprouting by cyclosporin A and itraconazole","volume":"6","author":"BA Nacev","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"ref69","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","article-title":"Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis","volume":"110","author":"AG Secchi","year":"1990","journal-title":"American journal of ophthalmology"},{"issue":"6","key":"ref70","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00003226-199311000-00004","article-title":"Immunological analysis and treatment of Mooren's ulcer with cyclosporin A applied topically","volume":"12","author":"JC Zhao","year":"1993","journal-title":"Cornea"},{"issue":"6","key":"ref71","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000268041","article-title":"Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis","volume":"29","author":"K Gunduz","year":"1997","journal-title":"Ophthalmic Res"},{"issue":"10","key":"ref72","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/bjo.2005.070888","article-title":"Topical ciclosporin in the treatment of ocular surface disorders","volume":"89","author":"S Tatlipinar","year":"2005","journal-title":"The British journal of ophthalmology"},{"issue":"5","key":"ref73","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","article-title":"Clinical review: topical ophthalmic use of cyclosporin A","volume":"18","author":"CA Utine","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"ref74","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2013-304072","article-title":"Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease","volume":"98","author":"M Sacchetti","year":"2014","journal-title":"The British journal of ophthalmology"},{"issue":"9","key":"ref75","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/ICO.0000000000000477","article-title":"Cyclosporine A Downregulates MMP-3 and MMP-13 Expression in Cultured Pterygium Fibroblasts","volume":"34","author":"YH Kim","year":"2015","journal-title":"Cornea"},{"issue":"4","key":"ref76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4196\/kjpp.2015.19.4.357","article-title":"Effect of Bevacizumab on Human Tenon's Fibroblasts Cultured from Primary and Recurrent Pterygium","volume":"19","author":"YM Park","year":"2015","journal-title":"Korean J Physiol Pharmacol"},{"issue":"7","key":"ref77","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1167\/iovs.13-11604","article-title":"Serum deprivation can suppress receptor-mediated calcium signaling in pterygial-derived fibroblasts","volume":"54","author":"C Fang","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"ref78","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10792-013-9732-8","article-title":"The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization","volume":"33","author":"BT Acar","year":"2013","journal-title":"Int Ophthalmol"},{"issue":"1","key":"ref79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02713680701799101","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium","volume":"33","author":"I Bahar","year":"2008","journal-title":"Curr Eye Res"},{"issue":"3","key":"ref80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3341\/kjo.2008.22.3.147","article-title":"Conjunctivolimbal autograft using a fibrin adhesive in pterygium surgery","volume":"22","author":"HH Kim","year":"2008","journal-title":"Korean J Ophthalmol"},{"issue":"6","key":"ref81","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1590\/S0004-27492006000600010","article-title":"Exposure of Tenon's capsule fibroblasts of pterygium to cyclosporin 0.05%","volume":"69","author":"LA Hercules","year":"2006","journal-title":"Arq Bras Oftalmol"},{"key":"ref82","first-page":"23","article-title":"Overexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts","volume":"17","author":"SC Chao","year":"2011","journal-title":"Mol Vis"},{"issue":"1","key":"ref83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0065-1281(89)80035-2","article-title":"Immunohistochemical localization of collagen types I, II, III, and IV in pterygium tissues","volume":"87","author":"Y Dake","year":"1989","journal-title":"Acta Histochem"},{"issue":"2","key":"ref84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.preteyeres.2004.02.002","article-title":"Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases","volume":"23","author":"N Di Girolamo","year":"2004","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"ref85","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1096\/fasebj.5.8.1850705","article-title":"Matrix metalloproteinases and their inhibitors in connective tissue remodeling","volume":"5","author":"JF Woessner Jr.","year":"1991","journal-title":"FASEB J"},{"issue":"31","key":"ref86","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2174\/092986710793213724","article-title":"Matrix metalloproteinases","volume":"17","author":"O Zitka","year":"2010","journal-title":"Curr Med Chem"},{"issue":"12","key":"ref87","first-page":"4823","article-title":"Interstitial collagenases as markers of tumor progression","volume":"6","author":"CE Brinckerhoff","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"39","key":"ref88","doi-asserted-by":"crossref","first-page":"37849","DOI":"10.1074\/jbc.M302946200","article-title":"Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis","volume":"278","author":"EH Sage","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"ref89","first-page":"214","article-title":"Effect of Avastin on the migration and invasion of pterygium fibroblasts","volume":"29","author":"W Liu","year":"2014","journal-title":"Eye Sci"},{"issue":"5","key":"ref90","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00347-009-1936-y","article-title":"Antiangiogenic therapy for pterygium recurrence","volume":"106","author":"S Leippi","year":"2009","journal-title":"Ophthalmologe"},{"issue":"2","key":"ref91","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/ICO.0b013e3182151e0e","article-title":"Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study","volume":"31","author":"K Lekhanont","year":"2012","journal-title":"Cornea"},{"issue":"6","key":"ref92","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/ICO.0b013e3182772d4e","article-title":"Topical application of bevacizumab as an adjunct to recurrent pterygium surgery","volume":"32","author":"EB Ozgurhan","year":"2013","journal-title":"Cornea"},{"issue":"4","key":"ref93","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4103\/0301-4738.120220","article-title":"Repeated bevacizumab injections versus mitomycin C in rotational conjunctival flap for prevention of pterygium recurrence","volume":"62","author":"M Ozsutcu","year":"2014","journal-title":"Indian J Ophthalmol"},{"issue":"10","key":"ref94","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4103\/0301-4738.171508","article-title":"A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients","volume":"63","author":"P Singh","year":"2015","journal-title":"Indian J Ophthalmol"},{"issue":"7","key":"ref95","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0181-5512(08)74384-5","article-title":"Effectiveness of topical ciclosporin A treatment after excision of primary pterygium and limbal conjunctival autograft","volume":"31","author":"A Aydin","year":"2008","journal-title":"J Fr Ophtalmol"},{"issue":"11","key":"ref96","first-page":"3430","article-title":"UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells","volume":"43","author":"N Di Girolamo","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"ref97","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00003226-199907000-00011","article-title":"Differential effects of epidermal growth factor and interleukin 6 on corneal epithelial cells and vascular endothelial cells","volume":"18","author":"M Nakamura","year":"1999","journal-title":"Cornea"},{"issue":"1","key":"ref98","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0625.1997.tb00141.x","article-title":"Differences in responses of interleukin-1 and tumor necrosis factor alpha production and secretion to cyclosporin-A and ultraviolet B-irradiation by normal and transformed keratinocyte cultures","volume":"6","author":"AV Marionnet","year":"1997","journal-title":"Exp Dermatol"},{"issue":"1","key":"ref99","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ico.0000133994.22392.47","article-title":"Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca","volume":"24","author":"B Strong","year":"2005","journal-title":"Cornea"},{"issue":"24","key":"ref100","doi-asserted-by":"crossref","first-page":"12198","DOI":"10.1073\/pnas.89.24.12198","article-title":"Transcription of the tumor necrosis factor alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells","volume":"89","author":"AE Goldfeld","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref101","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","article-title":"Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis","volume":"89","author":"N Pucci","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"ref102","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S0161-6420(02)01160-0","article-title":"Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium","volume":"109","author":"MF Al Fayez","year":"2002","journal-title":"Ophthalmology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0169675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T13:10:02Z","timestamp":1692623402000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0169675"}},"subtitle":[],"editor":[{"given":"Helen","family":"Fillmore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0169675","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,9]]}}}